Paracoccidioidomycosis (PCM) is the most prevalent mycosis in Latin America and is caused by a group of fungi within the Paracoccidioides genus. The disease may present clinical and pathological manifestations ranging from asymptomatic pneumonia pulmonary lesions, to disseminated forms involving multiple organs. Sulfonamides were the first drugs used to treat PCM and are still used against this fungal infection. Sulfa drugs are competitive antagonists of ρ-aminobenzoic acid (PABA), a reaction catalyzed by dihydropteroate synthase (DHPS). However, the molecular effects of sulfonamides against the Paracoccidioides genus are unknown. The aim of this work was to investigate the global mechanism of action of sulfamethoxazole on Paracoccidioides lutzii. Yeast cells were grown on minimum medium in the presence or absence of sulfamethoxazole to construct EST libraries. The representational difference analysis (RDA) technique was used to identify up-and down-regulated P. lutzii genes after treatment with sulfamethoxazole. Approximately six transcripts related to mitochondrial function were differentially expressed. To confirm the RDA and bioinformatics results, several relevant genes were studied with quantitative real-time polymerase chain reaction (qRT-PCR) to evaluate their levels of expression. To confirm the impact of sulfamethoxazole on mitochondria, we measured the reduction of tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) by P. lutzii with or without exposure to the drug. MTT assays reveal that sulfamethoxazole produces a marked dose-dependent adverse 
Introduction
Paracoccidioidomycosis (PCM), the most prevalent mycosis in Latin America [1] , is caused by at least two different species complexes: Paracoccidioides brasiliensis (harboring S1, PS2, PS3, and PS4 cryptic species) and Paracoccidioides lutzii. P. lutzii was recently proposed as a new species within the Paracoccidioides genus using molecular and morphological approaches [2, 3] . In Brazil, approximately 50% of the deaths caused by systemic mycoses between 1996 and 2006 were due to the Paracoccidioides genus [4] . The disease causes a broad spectrum of clinical and pathological manifestations, ranging from asymptomatic pulmonary lesions and mild respiratory infections to life-threatening disease that can involve multiple organs, most often the lungs, oropharyngeal mucosa, skin, lymph nodes, adrenal glands, and the central nervous system [5] .
Antifungal chemotherapy is required for PCM, although complete eradication of the fungus may not occur even after long-term therapy. Initial treatment depends on the severity of the disease and varies from 2 to 6 months; therapeutic options include sulfonamides, amphotericin B, and azoles. Extended periods of treatment are often necessary, up to 2 or more years, and relapsing disease frequently occurs [6, 7] . In the 1940s, sulfonamides were determined to be the first effective drug for the treatment of PCM [8] , and they continue to be used as standard treatment today, including for the severe childhood forms [6, 9] .
Sulfa drugs are competitive antagonists of ρ-aminobenzoic acid (PABA) [10] , which is condensed with 2-amino-4-hydroxy-6-hydroxymethyl-7,8 dihydropteridine pyrophosphate (DHPPP) to form dihydropteroate (DHP), a reaction catalyzed by dihydropteroate synthase (DHPS). DHPS is a key enzyme involved in folate synthesis [11] . Folate cofactors are involved in the biosynthesis of purines and pyrimidines (thymidylate), in the biosynthesis of amino acids such as glycine and methionine, and in the biosynthesis of vitamins such as pantothenic acid [12] . However, the mechanisms of action of sulfonamides on the fungal pathogen Paracoccidioides lutzii have not been defined.
Several studies of antifungal agents have identified genes that respond to these compounds [13, 14] . We use representational difference analysis (RDA) as optimized by Pastorian et al. [15] to identify genes that are differentially expressed by P. lutzii under different growth conditions [16] [17] [18] [19] [20] [21] . RDA is a sensitive and powerful tool for the identification of up-and down-regulated genes in two different populations of cDNA [22] .
The aim of this study was to assess the global response of P. lutzii to the effects of sulfamethoxazole. Using the RDA approach, we identified genes that were differentially expressed in P. lutzii in response to exposure to a sub-inhibitory concentration of sulfamethoxazole. The data were confirmed by quantitative realtime polymerase chain reaction (qRT-PCR) and reduction of tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). In addition, the transcript levels of selected genes were also measured during ex vivo macrophage infection. These changes in the gene expression profile provided insights into the mechanism of action of sulfamethoxazole on P. lutzii (formerly Paracoccidioides brasiliensis, isolate 01).
Materials and methods

P. lutzii culture and determination of cell viability
P. lutzii Pb01 (ATCC MYA-826) has been extensively studied in our laboratory [23] [24] [25] [26] . P. lutzii yeast cells were sub-cultured every seven days on semi-solid Fava-Netto's medium [1% (w/v) peptone; 0.5% (w/v) yeast extract; 0.3% (w/v) proteose peptone; 0.5% (w/v) beef extract; 0.5% (w/v) NaCl; 4% (w/v) glucose; 1% (w/v) agar, pH 7.2] [27] at 36
• C and used throughout this study.
The determination of IC 50 was performed according to Santo et al. [28] . The experiments were processed in triplicate. For viability experiments, yeast cells were grown in the presence or absence of 0.01 mg/mL (IC 50 ) of sulfamethoxazole, in liquid minimal medium McVeigh Morton (MMcM) [29] at 36
• C, and the viability of the cells at different time intervals was determined by the trypan blue method [30] . In brief, cells were incubated with a dye solution (0.1% trypan blue stain) for 5 min at room temperature and viability was assessed by counting viable and dead cells in a Neubauer chamber.
RNA isolation and cDNA synthesis P. lutzii yeast cells were grown in liquid Fava-Netto's medium for 72 h and then transferred to the liquid MMcM for 16 h. Then, P. lutzii yeast cells were grown in liquid MMcM for 1 h and 2 h in the presence and absence of 0.01 mg/mL sulfamethoxazole, and total RNA was extracted using Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The RNA was treated with RNAse-free DNAse I (Invitrogen) to remove chromosomal DNA. RNA purity was assessed by spectrophotometry using the A 260nm /A 280nm ratio and the integrity was inspected by 1.5% gel electrophoresis. The RNAs were used to construct subtracted cDNA libraries. The first-strand cDNA was synthesized from 1 µg of DNAse-treated RNAs using reverse transcriptase (RT Superscript III, Invitrogen) and used as a template to synthesize the second-strand using the SMART PCR cDNA synthesis kit (Clontech Laboratories, Palo Alto, CA, USA). ing in a Neubauer chamber. The cells were co-cultured for 24 h in the presence of 0.01 mg/ml of sulfamethoxazole at 37
• C in 5% CO 2 to allow fungal internalization. The supernatants were removed, and the cell layer was observed using light microscopy, to visualize fungal cells internalized by the macrophage. In addition, the number of viable fungi co-cultivated with the macrophages was determined by quantifying the number of colony-forming units (CFUs). In other wells, the monolayers were gently washed with 1X phosphate-buffered saline (PBS) to remove any nonadherent/internalization yeast cells, and the total RNA was isolated as described above.
RDA methodology
The cDNA libraries were generated using the RDA technique [15] with minor modifications. This subtractive hybridization strategy removes transcripts shared by the driver and tester populations and enriches the tester library for differentially expressed genes. Double-stranded cDNAs (1 µg) were digested with Sau3AI restriction enzyme (Amersham Biosciences, Little Chalfont, Uppsala, Sweden). The digestion products were linked to adapter primers and PCRamplified to generate cDNAs representations for the driver and tester. Two successive rounds of PCR amplifications employing different adapters (J-Bam and N-Bam, Table 2 ) were performed to enrich the differentially expressed sequences. In the first round, we hybridized the tester/driver at a ratio of 1:10; in the second round the tester/driver ratio was set at a higher stringency of 1:100. Before each round of hybridization, the cDNAs were purified using the GFX PCR purification kit (GE Healthcare UK, Little Chalfont, Buckinghamshire, England). In the RDA method, cDNA from yeast cells cultured in MMcM broth medium with 0.01 mg/ml of sulfamethoxazole for 1 and 2 h served as the tester population. They were hybridized to cDNA from yeast cells cultured in MMcM broth medium only, for 1 and 2 h as driver, and vice versa. This resulted in four differential expression libraries, two for up-regulated transcripts and two for down-regulated transcripts. The adapters used for subtractive hybridizations are listed in Table 2 .
The cDNAs from these libraries were cloned into a pGEM-T Easy vector (Promega, Madison, WI, USA) that was used to transform Escherichia coli XL1 Blue electro competent cells. The positive colonies were picked and grown in deep-well plates. The plasmid DNA was purified by a miniprep protocol (Qiagen, Venlo, Netherlands, Germany) and was used as the template in the standard fluorescence labeling dye-terminator protocols with a T7 flaking vector primer. The reaction products were loaded onto a MegaBACE 1000 DNA sequencing system (GE Healthcare) for automated sequence analysis.
Bioinformatics analysis
The reading quality of the sequences was checked by the Phred program module [31] , and we analyzed the sequences with at least 50 nucleotides and a quality grater or equal to 20. Then, the vector sequences were timed using the Crossmatch program [32] . Subsequently, the sequences were assembled using the CAP3 program [33] to obtain the final set of contigs and singlets. All these tools were integrated in a specific pipeline [34] . A search for functional categories was performed using the program Blast2GO [35] that provides a comparison between clusters of sequences obtained from public databases. The BLAST program of the National Center for Biotechnology Information (NCBI) [36] processed with non-redundant sequences (nr) GenBank and the nucleotide database generated from the P. lutzii structural genome [37] were used for the annotation of the ESTs. The database sequence matches were considered significant at e-values ≤10 −5 with sequence coverage cuts of 39.7%.
The program INTERPROSCAN [38] was used to obtain information about the classification of families. The metabolic pathways were analyzed using maps obtained from the KEGG database (Kyoto Encyclopedia of Genes and Genomes) [39] with annotated EC numbers, and this information was used to help elucidate the function of the ESTs. The Munich Information Center for Protein Sequences (MIPS) [40] was used to designate the functional categories.
Sequence analysis and the annotation pipeline were set up using the Blast2GO program, which joins in one GO application a similarity search with statistical analysis and highlighted visualization on a directed acyclic graph [41] . The Blast2GO annotation algorithm takes multiple parameters into account such as sequence similarity, blast HSP (highest scoring pair) length and e-values, the GO hierarchical structure and the GO term evidence codes [41, 42] .
For GO functions with up-or down-regulated genes, graphs were plotted for the times of exposure to the compound to demonstrate the statistically enriched genes of each functional category ( Supplementary Fig. 1 ). The percentage of the occurrence of each gene in relation to the total number of genes from the libraries was calculated and is shown in Supplementary Table 1.
Quantitative real-time PCR (qRT-PCR)
Total RNAs from P. lutzii yeast cells cultured in the presence or absence of sulfamethoxazole were obtained as previously described in independent experiments from those used in the RDA assays. After treatment with DNAse, first strand cDNAs were synthesized from total RNA Viability = Mean absorbance for each concentration of the extract − white × 100 Mean absorbance of control − white using Superscript II reverse transcriptase (Invitrogen) and an oligo (dT) 15 primer according to the supplier's instructions. Gene-specific primers were designed for the gene of interest and for the gene α-tubulin using Primer Express software (Applied Biosystems, Foster City, CA, USA). The qRT-PCRs were performed in triplicate in a StepOnePlus The SYBR green PCR master mix (Applied Biosystems) was used for each reactions and was supplemented with 1 ρmol of each gene-specific oligonucleotides and 40 ng of template cDNA in a final volume of 20 µl. A melting curve analysis was performed to confirm the amplification of a single PCR product. The data were normalized to the α-tubulin gene of P. lutzii. A nontemplate control was included. A cDNA for a relative standard curve was generated using an aliquot of cDNA from each sample. Relative expression levels of the genes of interest were calculated using the standard curve method for relative quantification [43] . Student's t-test was used for statistical comparisons and P values ≤ .05 were considered statistically significant. The specific sense and antisense primers are listed in Table 2 . at 180 rpm, 20 μl of MTT (Sigma-Aldrich) at 5 mg/ml was added to each well, and the plate was incubated for 4 h at 36
• C. The plate was then centrifuged at 800 rpm for 10 min, and the supernatant was removed. Next 100 μl of dimethyl sulfoxide (DMSO) (Vetec, Rio de Janeiro, RJ, Brazil) was added to each well for solubilization of formazan crystals; the plate was gently homogenized and the concentration of solubilized formazan was quantified spectrophotometrically using an ELISA reader (Stat Fax 2100, Awareness Technology, Dusseldorf, Germany) at a wavelength of 540 nm. The absorbance of control cells (untreated) was considered 100% cell viability; the white (medium control) contained only DMSO. The cytotoxicity of the compound was calculated as follows:
The MTT test was performed in triplicate, and each concentration of sulfamethoxazole was assessed in sextuplicate. The results of viability were plotted (Graphpad Prism 5.0, Software, San Diego, CA, USA).
Fluorescence microscopy
The fungus was subcultured at 36
• C on Sabouraud solid medium for 6 days and transferred to Fava-Netto liquid medium for 72 hours. Thereafter, the fungus was transferred to MMcM for 16 hours. An aliquot of 10 6 /ml of P.
lutzii yeast cells was added to MMcM containing three different concentrations of sulfamethoxazole: 0.64g/ml, 0.08 mg/ml and 0.01 mg/ml (at final volume of 200 µl).
After 24 h and 48 h of treatment, the cells were stained with 10 µM FUN-1 (Life Technologies) and viewed with an Olympus AX70 microscope with a 4 ,6-diamidino-2-phenylindole (DAPI) fluorescence filter [44] .
Results
Generation of RDA products cDNA libraries were constructed using 0.01 mg/ml sulfamethoxazole, which corresponds to the IC 50 for P. lutzii, at 1 and 2 h of incubation at 36 o C. Cell viability was ∼ 85% (data not shown). The libraries were constructed using the RDA technique as described [15] . Amplification of two rounds of RDA revealed different banding patterns of amplified fragments within each time interval (data not shown). After total RNA extraction and RDA assay, the differential products were isolated and cloned in a pGEM-T Easy vector and sequenced.
Global gene expression profile
A total of 683 ESTs were successfully sequenced and differentially regulated. From these, 77 and 187 up-and down-regulated genes, respectively, were obtained from P. lutzii yeast cells after incubation with sulfamethoxazole for 1 h; and 177 and 242 up-and down-regulated genes, respectively, after 2 h of incubation. For the library of up-regulated genes after 1 h of exposure of the fungus to sulfamethoxazole, a total of 16 genes were grouped into 20 clusters with 11 contigs and 9 singlets after pipeline analysis. For the library of up-regulated genes after 2 h, a total of 11 genes were grouped into 25 clusters with 12 contigs and 13 singlets. For the library of down-regulated genes after 1 h of exposure, a total of 34 genes were grouped into 52 clusters with 23 contigs and 29 singlets. For the library of down-regulated genes after 2 h, a total of 11 genes were grouped into 33 clusters with 16 contigs and 17 singlets. The ESTs were submitted to the National Center for Biotechnology Information (NCBI) under the following accession numbers: LIBEST_028467 Paracoccidioides sulfamethoxazole 1 h up Library, LIBEST_028466 Paracoccidioides sulfamethoxazole 1 h down Library, LIBEST_028469 Paracoccidioides sulfamethoxazole 2 h up Library and LIBEST_028468 Paracoccidioides sulfamethoxazole 2 h down Library. The RDA data from this study are available on the EST database (dbEST) at = under series. The differentially expressed genes were compared to P. lutzii genes in the Broad Institute database by Blast X. ESTs with an e-value < 10 −5 were identified. The contigs and singlets were annotated using the Blast2GO program. The classification by functional category and the general distribution of genes among various functional groups was obtained based on this annotation, according to the classification of GO (Table 1) . The GO functions with up-or down-regulated genes after exposure to sulfamethoxazole were plotted in graphs to demonstrate the statistically enriched function (Supplementary Fig. S1 ). The groups with the highest percentage of up-regulated genes were the cell rescue, defense and virulence (65%), metabolism (20%), cellular transport, transport facilities and transport routes, and unclassified proteins (6%), unclassified proteins (4%), transcription (2%), energy, protein fate and functional unclassified proteins (1%). The highest percentage of down-regulated genes were grouped in the metabolism (44%), transcription (20%), energy (11%), cell rescue, defense and virulence (10%), cell cycle and DNA processing, functional unclassified proteins and unclassified proteins (3%) and cellular transport, transport facilities and transport routes, protein synthesis, and protein fate (2%) groups.
The distribution of differentially expressed genes in biological functional groups was evaluated (Table 1 ; Fig. 1A and 1B). From this analysis, we observed that most of the genes down-regulated after 1 h of incubation participated in cellular processes related to transcription and cell rescue, defense and virulence. On the other hand, the upregulated genes primarily functioned in metabolism, cellular transport, transport facilities and transport routes. After 2 h, most of the down-regulated genes were involved in metabolism and the up-regulated genes were related to cell rescue, defense and virulence. The percentage of occurrence of each gene in the libraries is indicated in Supplementary  Table S1 .
Some genes from the respiratory complex group, such as ATP synthase subunit β (ATP2) and carnitine/acyl carnitine carrier (ACUH), as well as acyl-CoA dehydrogenase (ACAD) from β-oxidation, were down-regulated. Many genes involved in cell rescue, defense and virulence or cellular transport were up-regulated; for example, various heat shock proteins, and the major facilitator superfamily transporter (MFS) and the ABC transporter.
Treatment with sulfamethoxazole resulted in up-and down-regulated genes involved in different biological processes (Table 1 ; Fig. 2 ). Among potentially relevant genes and those that had more representation in the number of ESTs in response to sulfamethoxazole after 1 h of treatment that could be cited as up-regulated was cysteine desulfurase (NFS1). The down-regulated genes included C6 transcription factor (CTF1B), betaine aldehyde dehydrogenase (BADH), heat shock protein (HSP30), GATA-type sexual (NSDD), carnitine/acyl carnitine carrier (ACUH) and ribonuclease reductase large subunit (RNR1). Table 1 ). The functional classification was based on homology of each EST against the GenBank non-redundant database at a significant homology cut-off ≤ 1e
and on the MIPS functional annotation scheme. Each functional class is represented as a segment and is expressed as the number of ESTs in each library. Table 2 . Oligonucleotides primers used in RDA assay and qRT-PCR. Similarly, treatment with sulfamethoxazole for 2 h also revealed up-and down-regulated genes involved in different biological processes (Table 1; Fig. 2) . After 2 h of treatment with sulfamethoxazole, the up-regulated genes included those for heat shock protein (HSP70), heat shock protein (HSP60), and heat shock protein (HSP30). The down-regulated genes included betaine aldehyde dehydrogenase (BADH), carnitine/acyl carnitine carrier (ACUH), guanine nucleotide binding protein α-1 subunit (GPA2), C6 transcription factor (CTF1B) and pleckstrin homology domain (PH) (Table 1; Fig. 2 ).
Analysis of RNA transcripts by qRT-PCR
To confirm the data from RDA libraries, the transcriptional levels of selected genes related to mitochondrial functions and cellular metabolism, including β-oxidation, that were identified as regulated by RDA analysis were measured by qRT-PCR. Target genes included ATP2, transmembrane GTPase (FZO1), ACAD, 3-demethylubiquinone-9 3-methyltransferase (COQ3), ubiquitin (UBI), ACUH, NADPH dehydrogenase (OYE), succinate/fumarate mitochondrial transporter (ACR1), and glutamine synthetase (GLN1). In general, the transcripts expression levels were similar to those identified by RDA and bioinformatic analyses (Fig. 3A) .
The enzyme dihydropteroate synthase (DHPS) previously described as a target of sulfamethoxazole in fungi [45] , and dihydrofolate reductase (DHFR), the last enzyme in the biosynthesis of folate cofactors, were not found by our RDA approach. These two enzymes were analyzed by qRT-PCR, revealing that the transcriptional levels of DHFR were only high after 6 h of exposure of P. lutzii yeast cells to sulfamethoxazole (Fig. 3B) . However, DHPS was down regulated at all time points.
Transcripts level in P. lutzii yeast cells treated with sulfamethoxazole after internalization in macrophage cells
To investigate whether the regulated transcripts identified by the RDA method would be regulated during hostpathogen interactions, P. lutzii yeast cells were internalized by J774A.1 macrophage-like cells and the transcript levels were quantified. J774A.1 mouse macrophage-like cells were infected with P. lutzii and treated with sulfamethoxazole for 24 h, and qRT-PCR analysis was carried out for the genes ATP2, DHPS, and DHFR. ATP2 and DHPS were down-regulated in the library and qRT-PCR assays, and their expression levels were significantly lower after 24 h of infection in the sulfamethoxazole-treated cells (Fig. 3C) . Figure 2 . Distribution of genes responding to sulfamethoxazole in P. lutzii. The data are shown for a subset of genes that were significantly up-or down-regulated. The data were organized into various biological process using Functional Categories MIPS and GO tools. The parentheses show the time interval at which the alterations were detected, with "+" indicating up-regulation and "−" down-regulation. A complete list of all significant genes can be found in Table 1 .
Similarly, DHFR was up-regulated in the qRT-PCR assays, and the level of DHRF was significantly higher after 24 h of infection in the presence of sulfamethoxazole.
MTT assay and Fluorescence microscopy
The MTT assay is an alternative method for measuring metabolic cellular function based on the transformation and colorimetric quantification of MTT. The respiratory chain [46] and other electron transport systems [47] reduce MTT and other tetrazolium salts and form non-water-soluble violet formazan crystals within the cell [48] . The amount of these crystals can be determined spectrophotometrically, and this serves as an estimate for the number of functional mitochondria and hence the number of living cells in the sample [49] . This assay has been used successfully to verify mitochondrial reduction capacity and viability [50] . The MTT method was used to verify the impact of sulfamethoxazole on P. lutzii mitochondrial activity. Sulfamethoxazole (0.01-1.28 mg/mL) produced a marked dose-dependent adverse effect on P. lutzii (Fig. 4A) .
To further assess if sulfamethoxazole treatment leads to mitochondrial dysfunction, we used a fluorescence microscopy assay. We stained the P. lutzii yeast cells with 10 µM FUN after 24 and 48 h of treatment with three different concentrations of sulfamethoxazole ( Fig. 4B and 4C) . In metabolically active yeast cells, FUN-1 is transported to the vacuole and converted into a cylindrical intravacuolar structure (CIVS) that has a distinct orange-red fluorescence when excited by light from 470 nm to 590 nm. This process is mitochondrial-ATP dependent. The CIVS is completely abrogated by inhibition of mitochondrial cytochrome oxidase with sodium azide or sodium cyanide [51] . At 24 h, we observed a small decrease in activity at the subinhibitory concentrations tested. However, the impact of sulfamethoxazole at 48 h produced a notable dose dependent reduction that corroborates the MTT results.
Discussion
PCM is a granulomatous chronic mycoses [52] . Spontaneous cure is uncommon in PCM, except in some cases of primary lung infections [53] . Treatment of PCM includes the use of antifungal drugs and nutritional support, as well as the treatment of the sequelae of the disease and prevention of opportunistic diseases [54, 55] . Although sulfamethoxazole has long been a mainstay of antimicrobial therapy, the mechanism of action of this drug against the Paracoccidioides genus has remained unknown. This study describes the cellular responses of P. lutzii, at a transcriptional level, to sulfamethoxazole exposure.
An RDA study was performed in P. lutzii yeast cells with or without exposure to sulfamethoxazole, and the results were confirmed by qRT-PCR and MTT assays. In addition, selected genes were also analyzed after infection with in cocultures of P. lutzii and macrophages with or without sulfamethoxazole in the medium. The differentially expressed genes were involved in multiple biochemical functions. Our particular interest was the striking alterations in the regulation of energy-metabolism-related genes after sulfamethoxazole treatment: the down-regulated mitochondrial genes and the up-regulated genes associated with the biosynthesis of amino acids, purine and pyrimidine, which are involved in folate cofactor production.
Sulfa drugs inhibit Saccharomyces cerevisiae growth through competition with PABA, which is the precursor for the biosynthesis of folate cofactors that are active in the metabolism of single carbons [56] . Thus, one-carbon units that are carried and donated by tetrahydrofolate derivatives are essential for providing active one-carbon groups to the biosynthesis of methionine as well as to purines and thymidylate [57] . In S. cerevivisiae, as well as in other eukaryotes, both the cytoplasmic and mitochondrial compartments possess a set of enzymes that catalyze the interconversion of folate coenzymes. In the cytoplasm, the folate coenzymes participate in the synthesis of methionine, purines, and thymidylate. In the mitochondria, folate is required for the formylation of the initiator tRNA for mitochondrial protein synthesis [12] . In S. cerevisiae, one-carbon donors such as serine, glycine, and formate are able to cross the mitochondrial membrane [58] . Mitochondrial protein synthesis is required for maintenance of an intact mitochondrial genome in S. cerevisiae [59] . Moreover, inhibition of mitochondrial protein synthesis by the use of antifolates induces cytoplasmic respiration-deficient strains [60] .
Our data allowed the identification of genes in the P. lutzii transcriptome that are impacted by sulfamethoxazole treatment. Interestingly, sulfamethoxazole-treated cells displayed significant reductions in protein expression levels by genes involved in mitochondrial functions. For instance, ACR1 was significantly down regulated after 1 h of exposure. In S. cerevisiae, Acr1p can specifically counter transport succinate and fumarate, which are known to be transporters for several substrates at the inner mitochondrial membrane [61] . ACR1 is thus strictly coregulated with the genes for key enzymes of the glyoxylate cycle and gluconeogenesis. Supporting the idea that Acr1p is the factor that transports succinate from the cytosol into the mitochondrial matrix in exchange for fumarate, ACR1 form an essential link between the glyoxylate and TCA cycles during growth on ethanol or acetate [62] . In addition, the expression of ACR1 is repressed by glucose [63] . ACR1 makes a small contribution to the basal proton conductance of yeast mitochondria [64] . Thus, the down-regulation of ACR1 at 1 h could contribute to a dysregulated potential of membranes in P. lutzii, resulting in the dysfunction of the electron transport chain and ATP production.
The other major classes of down-regulated genes were those involved in ATP energy metabolism. Our data revealed that in P. lutzii, sulfamethoxazole significantly down regulated ATP2 expression. The F1F0-ATPase or ATP synthase rotates inside the cylinder formed by the six α and β subunits, and it compels the β subunits to undergo structural changes [65] . Because the expression of ATP synthase subunit β was decreased in the fungus treated with sulfamethoxazole, this could disrupt the production of ATP. In contrast to the suppression of ATP2, the expression level of the potential mitochondrial inner membrane ATP/ADP carrier protein (AAC) was increased after 1 h of sulfamethoxazole exposure. From these results, we postulate that mitochondrial ATP synthesis is reduced as a result of the inhibition of F1F0-ATPase and that the reduction in mitochondrial ATP is further accelerated by the transport of ATP from the mitochondrial matrix to the cytoplasm by increased expression of the AAC translocator.
The results from our work suggest that the efficiency of mitochondrial aerobic respiration would be decreased after sulfamethoxazole treatment. To test this hypothesis, functional analysis was carried out to measure mitochondrial activity in P. lutzii with or without exposure to sulfamethoxazole by using the MTT assay. The results demonstrated a reduction of P. lutzii mitochondrial activity in a dose-dependent manner, confirming the transcriptional data. The finding of a dose dependent reduction in FUN-1 staining further supports our finding that mitochondrial activity is affected by sulfamethoxazole.
Aspergillus nidulans contains both peroxisomal and mitochondrial β-oxidation pathways, and the genes encoding the proteins required for mitochondrial β-oxidation of even-numbered short chain fatty acids but not long chain fatty acids have been identified [66, 67] . In A. nidulans, the catabolism of fatty acids begins with oxidation in the peroxisome to generate acetyl-CoA, which is transported into the mitochondria for its complete oxidation by the TCA. Acetyl moieties are imported into the mitochondria as esters with carnitine using the mitochondrial inner membrane carnitine/acylcarnitine carrier encoded by the ACUH gene [68] . Localization studies have clearly demonstrated the exclusive targeting of the ACUH gene product to the mitochondrial inner membrane [69, 70] . In P. lutzii, the genes ACUH and ACAD were repressed after 1 h of exposure to sulfamethoxazole, which could compromise mitochondrial β-oxidation.
We propose a model for the mode of action of the sulfamethoxazole transcripts taking into account the available literature and our observations reported here. We could infer that sulfamethoxazole treatment results in (i) dissipation and permeabilization of the mitochondrial membrane potential, because COQ3 and ATP2 were down-regulated, and AAC is up-regulated; (ii) inhibition of gluconeogenesis precipitated by down-regulation of transporter ACR1; (iii) inhibition of β-oxidation by repression of ACAD and ACUH. The decrease in ATP production by F1F0-ATPase results from down-regulation of the ATP2 subunit. In sum, the key steps in the antifungal mechanism of sulfamethoxazole involve a bioenergetic collapse of P. lutzii caused essentially by a decrease in mitochondrial ATP synthesis (Fig. 5) .
Beyond the bioenergetic collapse caused by the repression of energy-metabolism-related genes, mitochondrial biogenesis in P. lutzii could be impaired by the downregulion of FZO1. Maintaining the capacity of the mitochondria to fuse normally is essential for the inheritance of mtDNA and for respiration. Fragmentation of the mitochondria leads to a loss of mtDNA and respiratory incompetence in S. cerevisiae [71] . Regulating levels of expression of Fzo1p is of critical importance; deletion or over expression of Fzo1p alters the mitochondrial fusion process resulting in fizzed or abnormal aggregated mitochondria, respectively [71, 72] .
GLN1 catalyzes the condensation of glutamate and ammonium to form glutamine, with concomitant hydrolysis of ATP [73] . Glutamate and glutamine are used as amino donors in all other biosynthetic reactions [74] . Glutamine can also be used as a sole nitrogen source [75] . GLN1 is involved in nitrogen metabolism via regulation by Gln3p or Gcn4p. Gcn4 is a transcription factor whose activity increases under amino acid starvation conditions in S. cerevisiae [76, 77] . Moreover, the enzyme ρ-aminobenzoate synthase catalyzes the conversion of chorismate and glutamine, a product of GLN1, to an unidentified intermediate that is converted to PABA by a second enzyme [78] . PABA is essential for the biosynthesis of dihydrofolate, which in various forms participates in the synthesis of purines, pyrimidines, formylmethionyl-tRNA, and some amino acids and vitamins [79] .
Finally, we suggest that in P. lutzii the product of GLN1 could be donating nitrogen for the synthesis of nucleic acids and amino acids, or even for the metabolism of purines or condensing with chorismate to produce the substrates for the biosynthetic pathway of folate cofactors.
Chorismate is a common intermediate in the biosynthesis of aromatic metabolites such as aromatic amino acids and folate cofactors [80] . The shikimate pathway starts with the condensation of erythrose-4-phosphate and phosphoenolpyruvate to 3-deoxy-D-arabino-heptulosonate-7-phosphate, which is converted to the branch point compound chorismate [81] . Chorismate is also a precursor for the aromatic amino acids tyrosine, phenylalanine, and tryptophan, which can polymerize to melanin, a virulence factor in Paracoccidioides genus. Erythrose-4-phosphate is the end product of pentose phosphate pathway, which is involved in the action of the enzyme ribulose-phosphate 3-epimerase (RPE1) that is over expressed in P. lutzii treated with sulfamethoxazole at 1 h. We propose that GLN1 and RPE1 could be participating in the production of substrates for the biosynthesis of folate cofactors, which is most likely a compensatory mechanism because, as already described for other fungi, sulfamethoxazole inhibits this pathway [45, 10, 11] . The pentose phosphate pathway is required for NADPH generation and nucleotide biosynthesis [82] .
Although sulfamethoxazole inhibits the DHPS enzyme [45, 10, 11] , the DHPS transcript was not found in our RDA analysis; however qRT-PCR analysis showed that the transcript level was reduced after 6 h of exposure to the compound as well as in co-cultures with macrophages when sulfamethoxazole was in the growth medium. An inhibitory effect at the transcript level to protein production by a compound not specifically targeting this process has been described in Candida albicans [83] . High concentrations of echinocandin, which inhibits the enzyme (1,3)-β-D-glucan synthase, suppressed C. albicans RNA synthesis consistent with an off-target effect. Interestingly, in contrast to DHPS, P. lutzii DHFR expression significantly increased after 6 h of exposure to sulfamethoxazole, and gene expression similarly increased in the co-cultures with macrophages exposed to the drug. Hence, in our system, we suggest that P. lutzii DHFR compensates for the small quantity of product formed by DHPS enzyme inhibitory competition with PABA and sulfamethoxazole.
Drug resistance is often associated with the over expression of genes encoding efflux pumps [84] . Two classes of efflux pumps, membrane transport proteins belonging either to the major facilitator superfamily (MFS) or to the ATP-binding cassette (ABC) superfamily, have been implicated in azole resistance [85] . The over expression of genes encoding efflux pumps is presumed to prevent accumulation of itraconazole in the fungal cell [86] . In Candia glabrata, azole resistance can occur with mitochondrial dysfunction. Cells with mitochondrial DNA deficiency and upregulated ABC transporter genes display increased resistance to azoles [87, 88] . Our results suggest that this process could also occur in P. lutzii in response to sulfamethoxazole because the MFS and ABC transporters are up-regulated after 1 h of treatment.
The response of P. lutzii to sulfamethoxazole includes changing the profile of HSPs. HSPs are linked to cellular responses to various stressors such as changes in temperature and pH, the action of cytotoxic drugs, and oxidative stress [89] [90] [91] [92] . The alterations in HSPs in response to sulfamethoxazole is are not surprising as these molecules are responsible for preventing damage to proteins [93] .
Conclusions
This study is the first to our knowledge to analyze the changes in the P. lutzii transcriptional profile following sulfamethoxazole exposure. The results indicated that sufamethoxazole acts in P. lutzii as a competitor for the synthesis of amino acids, nucleic acids and precursors of the biosynthesis of folate cofactors resulting in the dysregulation of mitochondrial functions.
Our results demonstrate that sulfamethoxazole treatment impairs mitochondrial fitness and induces the overexpression of genes related to biosynthesis of amino acids and nucleic acids in P. lutzii, as well as genes linked to the biosynthesis of precursors in the synthesis of folate cofactors. As a whole, our findings regarding these biochemical processes involved in the mechanism of the action of sulfamethoxazole against P. lutzii provide significant insights that may lead to future drug design as well as provide new mechanistic information to clinicians caring for patients with PCM.
